No Data
No Data
Should You Investigate Hims & Hers Health, Inc. (NYSE:HIMS) At US$28.15?
Insider Sale: Chief Commercial Officer of $HIMS (HIMS) Sells 7,500 Shares
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $42
Strong Buy Recommendation for Hims & Hers Health Amid Growth Potential and Market Volatility
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating